Publications by authors named "Peter Blank"

Claim this Profile
L
Late Morbidity and Mortality in Survivors of Childhood Ependymoma: A Report from the Childhood Cancer Survivor Study (CCSS).
Katharine R Lange, Peter de Blank, Mengqi Xing, Sedigheh Mirzaei, Deo Kumar Srivastava

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Tonic Signaling Code Predicts CAR-T Cell Efficacy in Diffuse Midline Glioma.
Emily B Deng, Xiaowen Zhong, Dazhuan Xin, Upendra K Soni, Wenkun Ma, Peter de Blank

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.
Zaili Luo, Mingyang Xia, Wei Shi, Chuntao Zhao, Jiajia Wang, Peter de Blank

Nature· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomic-based prognostic score for survival risk-stratification in pediatric medulloblastoma tumors: A multi-institutional study.
Marwa Ismail, Hyemin Um, Gustavo Pineda, Ralph Salloum, Fauzia Hollnagel, Peter de Blank

Neurooncol Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative Multi-Omics Analysis Identifies Nuclear Factor I as a Key Driver of Dysregulated Purine Metabolism in DIPG.
Ian Mersich, Sunny Congrove, Matthew Horchar, Roman Caceres, Ranjithmenon Muraleedharan, Peter de Blank

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isotretinoin has no effect on event-free survival across high-risk medulloblastoma molecular groups when added to maintenance: A secondary analysis of the Children's Oncology Group ACNS0332 data.
Scott Raskin, Peter de Blank, Catherine A Billups, Yimei Li, James M Olson

Neurooncol Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over 3 decades.
Chiara Papini, Sedigheh Mirzaei, Mengqi Xing, Ingrid Tonning Olsson, Ralph Salloum, Peter M K de Blank

Neuro Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serologic Evidence of Recent Infection with Highly Pathogenic Avian Influenza A(H5) Virus Among Dairy Workers - Michigan and Colorado, June-August 2024.
Alexandra M Mellis, Joseph Coyle, Kristen E Marshall, Aaron M Frutos, Jordan Singleton, Peter Blank

MMWR Morb Mortal Wkly Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-grade glioma in children with neurofibromatosis type 1: surveillance, treatment indications, management, and future directions.
Chelsea Kotch, Peter de Blank, David H Gutmann, Michael J Fisher

Childs Nerv Syst· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Dysfunction in Children and Young Adults Treated With MEK Inhibitors: A Retrospective, Single-Center Study.
Jonathan D Bender, Natasha Pillay-Smiley, Garick D Hill, Peter de Blank, Trent R Hummel

JACC CardioOncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
nnU-Net-based Segmentation of Tumor Subcompartments in Pediatric Medulloblastoma Using Multiparametric MRI: A Multi-institutional Study.
Rohan Bareja, Marwa Ismail, Douglas Martin, Ameya Nayate, Ipsa Yadav, Peter de Blank

Radiol Artif Intell· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition.
Patricia O'Hare, Tabitha Cooney, Peter de Blank, David H Gutmann, Mark Kieran

Neuro Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Radiomic Approach for Evaluating Intra-Subgroup Heterogeneity in SHH and Group 4 Pediatric Medulloblastoma: A Preliminary Multi-Institutional Study.
Marwa Ismail, Hyemin Um, Ralph Salloum, Fauzia Hollnagel, Raheel Ahmed, Peter de Blank

Cancers (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Brain Tumor Segmentation (BraTS) Challenge 2023: .
Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu, Debanjan Haldar, Zhifan Jiang, Peter de Blank

ArXiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.
Yazmin Odia, Carl Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera

Neuro Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study.
Peter M K de Blank, Katharine R Lange, Mengqi Xing, Sedigheh Mirzaei Salehabadi, Deokumar Srivastava

Nat Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group.
Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, Thomas S Jacques, Pratiti Bandopadhayay, Peter de Blank

Neuro Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma.
Chiara Papini, Sedigheh Mirzaei S, Mengqi Xing, Ingrid Tonning Olsson, Peter M K de Blank

J Natl Cancer Inst· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new era for myelin research in Neurofibromatosis type 1.
Peter de Blank, Akiko Nishiyama, Alejandro López-Juárez

Glia· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials: A plea to cooperative groups, consortia, pharmaceutical companies, and lead investigators for reasonable imaging protocols.
Andrew T Trout, Robin E Norris, Peter M K de Blank, Lori R Backus, Alexander J Towbin

Pediatr Blood Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual presentation of bilateral optic pathway glioma in Crouzon Syndrome.
Brian Na, Anthony C Wang, Christopher Travis Watterson, Julian Martinez-Agosto, Sulagna Saitta, Peter de Blank

Pediatr Hematol Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shedding New Light: Novel Therapies for Common Disorders in Children with Neurofibromatosis Type I.
Natasha Pillay-Smiley, Jonathan S Fletcher, Peter de Blank, Nancy Ratner

Pediatr Clin North Am· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors.
Marwa Ismail, Stephen Craig, Raheel Ahmed, Peter de Blank, Pallavi Tiwari

Diagnostics (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Focal Areas of Signal Intensity (FASI) in Children with Neurofibromatosis Type-1 (NF1) Treated with Selumetinib on Pediatric Brain Tumor Consortium (PBTC)-029B.
Natasha Pillay-Smiley, James Leach, Adam Lane, Trent Hummel, Jason Fangusaro, Peter de Blank

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study.
Sukanya Iyer, Marwa Ismail, Benita Tamrazi, Ralph Salloum, Peter de Blank

Front Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis